G1 THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
G1 THERAPEUTICS, INC. reported Earnings Per Share, Basic and Diluted of -$1.15 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.15.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.94.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.00.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.94.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$3.54.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.62.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$3.27.
- G1 THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.15 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | -$0.94 10-K · filed 2022-02-23 | -$3.54 10-K · filed 2022-02-23 | ||
| 2021-09-30 | -$1.00 10-K · filed 2022-02-23 | -$2.60 10-Q · filed 2021-11-03 | ||
| 2021-06-30 | -$0.94 10-K · filed 2022-02-23 | -$1.59 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | -$0.65 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$0.67 10-K · filed 2022-02-23 | -$2.62 10-K · filed 2022-02-23 | ||
| 2020-09-30 | -$0.31 10-K · filed 2022-02-23 | -$1.95 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | -$0.83 10-K · filed 2022-02-23 | -$1.65 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | -$0.82 10-K · filed 2022-02-23 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-02-23 | -$2.63 derived: net income ÷ weighted average shares · filed 2022-02-23 | -$3.45 derived: net income ÷ weighted average shares · filed 2022-02-23 |
| 2019-12-31 | -$0.94 10-K · filed 2021-02-24 | -$1.81 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.62 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$3.27 10-K · filed 2022-02-23 |
| 2019-09-30 | -$0.86 10-K · filed 2021-02-24 | -$1.68 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.32 10-Q · filed 2020-11-04 | -$2.97 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-06-30 | -$0.82 10-K · filed 2021-02-24 | -$1.46 10-Q · filed 2020-08-05 | -$2.11 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.70 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-03-31 | -$0.64 10-K · filed 2021-02-24 | -$1.29 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.88 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.52 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2018-12-31 | -$0.65 10-K · filed 2020-02-26 | -$1.24 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.87 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.56 10-K · filed 2021-02-24 |
| 2018-09-30 | -$0.59 10-K · filed 2020-02-26 | -$1.22 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.91 10-Q · filed 2019-11-05 | -$2.52 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-06-30 | -$0.64 10-K · filed 2020-02-26 | -$1.33 10-Q · filed 2019-08-07 | -$1.93 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.49 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-03-31 | -$0.70 10-K · filed 2020-02-26 | -$1.30 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.85 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.73 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2017-12-31 | -$0.60 10-K · filed 2019-02-28 | -$1.15 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.03 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$3.57 10-K · filed 2020-02-26 |
| 2017-09-30 | -$0.55 10-K · filed 2019-02-28 | -$1.46 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$3.24 10-Q · filed 2018-11-07 | -$5.23 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2017-06-30 | -$1.09 10-K · filed 2019-02-28 | -$4.09 10-Q · filed 2018-08-08 | -$7.66 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$11.06 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2017-03-31 | -$11.24 10-K · filed 2019-02-28 | -$19.01 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$24.22 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$29.86 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2016-12-31 | -$7.77 10-K · filed 2018-02-21 | -$12.98 derived: net income ÷ weighted average shares · filed 2018-02-21 | -$18.61 derived: net income ÷ weighted average shares · filed 2018-02-21 | -$23.33 10-K · filed 2019-02-28 |
| 2016-09-30 | -$5.21 10-K · filed 2018-02-21 | -$10.83 derived: net income ÷ weighted average shares · filed 2018-02-21 | -$15.55 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$5.63 10-K · filed 2018-02-21 | -$10.34 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$4.71 10-K · filed 2018-02-21 | |||
| 2015-12-31 | -$16.13 10-K · filed 2018-02-21 |